In order to achieve the maximum therapeutic benefit in the treatment of malignancies, doses of chemotherapeutic agents are pushed to the point of severe marrow toxicity. This aggressive therapy can lead to iatrogenic complications including haemorrhage and sepsis due to the depletion of platelets and granulocytes. Prior to the advent of platelet transfusions, haemorrhage was the leading cause of death in these patients.1 Advances in blood banking and the availability of platelet transfusions have markedly decreased the incidence of fatal haemorrhage. As a result, infection has become the leading cause of death in patients with marrow failure.2 Although the risk of infection in patients with neutropenia has been well documented,3 the role of granulocyte transfusions in the treatment and prevention of these infections remains controversial. This paper will attempt to review the currently available literature regarding granulocyte procurement techniques and the efficacy of granulocyte transfusions.
HershE.M., BodeyG.P., NiesB.A., FreireichE.J.Causes of death in acute leukemia. A ten-year study of 414 patients from 1954–1963. JAMA1965; 193: 99–103.
2.
LevineA.S., SchimpffS.C., GrawR.G.Jr., YoungR.C.Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Semin Hematol1974; 11: 141–202.
3.
BodeyG.P., BuckleyM., SatheY.S., FreireichE.J.Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med1966; 64: 328–340.
4.
AthensJ.W., HaabO.P., RaabS.O.Leukokinetic studies IV. The total blood, circulating and marginal granulocyte pools and granulocyte turnover rate in normal subjects. J Clin Invest1961; 40: 989–991.
5.
MarshJ.C., BoggsD.R., CartwrightG.E., WintropeM.M.The effect of pneumococcal infection on neutrophil kinetics. J Clin Invest1969; 48: 1021–1031.
6.
FreirichE.J., LevineR.H., WhangJ.The function and fate of transfused leukocytes from donor with chronic myelocytic leukemia in leukopenic recipients. Ann Y Acad Sci1966; 64: 328–333.
7.
DjerassiI., KimJ.S., SuvansriU., CiesielkaW.Filtration leukapheresis: principles and techniques for harvesting and transfusion of filtered granulocytes and monocytes. In Leukocytes: Separation, Collection, and Transfusion.GoldmanJ.M., LowenthalR.M. eds. Academic Press, New York1975; 125–136.
8.
RussellJ.A., PowlesR.L.Blood transfusions and blood products. In: Clinics in Haematology, vol. 5. CashJ.D., ed. WB Saunders, Philadelphia1976; 81–93.
9.
MishlerJ.M., HadlockD.C., FortunyI.E., NicoraR.W., McCulloughJ.J.Increased efficacy of leukocyte collection by the addition of hydroxyethyl starch to the continuous-flow centrifuge. Blood1974; 44: 571–581.
10.
BenbunanM., BusselA., GrangeM.J., RevironJ., BernardJ.Collection by blood cell separator and in vitro function of normal granulocytes. In: Leukocytes: Separation, Collection, and Transfusion.GoldmanJ.M., LowenthalR.M., eds. Academic Press, New York, New York1975; 81–87.
11.
LowenthalR.M., GoldmanJ.M., BuskardN.A.Granulocyte transfusions in the treatment of infections in patients with acute leukaemia and aplastic anaemia. Lancet1975; i: 353–358.
12.
HerzigG.P., RootR.K., GrawR.G.Jr.Granulocyte collection by continuous-flow leukapheresis. Blood1972; 39: 554–567.
13.
HigbyD.J., YatesJ.W., HendersonE.S., HollandJ.F.Filtration leukapheresis for granulocyte transfusion therapy. N Engl J Med1975; 292: 761–766.
14.
GrawR.G.Jr., HerzigG., PerryS., HendersonE.S.Normal granulocyte transfusion therapy: treatment of septicaemia due to gram-negative bacteria. N Engl J med1972; 287: 367–371.
15.
SchifferC.A., AisnerJ., WiernikP.H.Transient neutropenia induced by transfusion of blood exposed to nylon fiber filters. Blood1975; 45: 141–146.
CliftR.A., SandersJ.E., ThomasD., WilliamsB., BucknerC.D.Granulocyte transfusions for the prevention of infection in patients receiving bone-marrow transplantation. N Engl J Med1978; 298: 1052–1057.
18.
EpsteinR.B., CliftR.A., ThomasE.D.The effect of leukocyte transfusions on experimental bacteremia in the dog. Blood1969; 34: 782–790.
19.
AppelbaumF.R., BowlesC.A., MakuchR.W., DeisserothA.B.Granulocyte transfusions therapy of experimental pseudomonas septicemia: Study of cell dose and collection technique.
20.
FortunyI.E., BloomfieldC.D., HadlockD.C.Granulocyte transfusion: A controlled study in patients with acute nonlymphocytic leukemia. Transfusion1975; 15: 548–558.
21.
AlaviJ.B., RootR.K., DjerassiI.A randomized clinical trial of granulocyte transfusions for infection in acute leukemia. N Engl J Med1977; 296: 706–711.
22.
HerzigR.H., HerzigG.P., GrawR.G., BullM.I., RayK.K.Successful granulocyte transfusion therapy for gram-negative septicemia. N Engl J Med1977; 296: 701–705.
23.
BerkmanE.M., EisenstaedtR.S., CaplanS.N.Supportive granulocyte transfusion in the infected severely neutropenic patient. Transfusion1978; 18: 693–700.
24.
DahlkeM.B., KeashenM., AlaviJ.B., KochP.A., EisenstaedtJ.K.Granulocyte transfusions and outcome of alloimmunized patients with gram-negative sepsis. Transfusion1982; 22: 374–378.
25.
WinstonD.J., HoW.G., GaleR.P.Therapeutic granulocyte transfusions for documented infections: a controlled trial in ninety-five infectious granulocytopenic episodes. Ann Int Med1982; 97: 509–515.
26.
VoglerW.R.A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med1977; 63: 548–555.
PoleJ.G., DavieM., KershawI., BarterD.A., WilloughbyM.L.Granulocyte transfusion in treatment of infected neutropenia children. Arch Dis Chil1976; 51: 521–527.
33.
HigbyD.J., FreemanA., HendersonE.S., SinksL., CohenE.Granulocyte transfusions in children using filter-collected cells. Cancer1976; 38: 1407–1413.
34.
MaybeeD.A., MillanA.P., RuymannF.B.Granulocyte transfusion therapy in children. So Med J1977; 70: 320–324.
35.
SteinherzP.G., ReichL.M.Granulocyte transfusions in infected neutropenic children with malignancies. Med Ped One1979; 6: 65–76.
36.
ChristensenR.D., RothsteinG., AnstallH.B., BybeeB.Granulocyte transfusions in neonates with bacterial infection, neutropenia, and depletion of mature marrow neutrophils. Pediatrics1982; 70: 1–6.
37.
CairoM.S., RuckerR., BennetsG.A.Improved survival of newborns receiving leukocyte transfusions for sepsis. Pediatrics1984; 74: 887–892.
38.
BaleyJ.E., StorkE.K., WarkentinP.I., ShurinS.B.Buffy coat transfusions in neutropenic neonates with presumed sepsis: A prospective, randomized trial. Pediatrics1987; 80: 713–720.
39.
WheelerJ.G., ChauvenetA.R., JohnsonC.A.Buffy coat transfusions in neonates with sepsis and neutrophil storage pool depletion. Pediatrics1987; 79: 423–425.
WinstonD.J., HoW.G., HowellC.L.Cytometalovirus infections associated with elukocyte transfusions. Ann Intern Med1980; 93: 671–675.
42.
HersmanJ., MeyersJ.D., ThomasE.D., BucknerC.D., CliftR.The effect of granulocyte transfusions upon the incidence of cytomegalovirus infection after allogeneic marrow transplantation. Ann Intern Med1982; 96: 149–152.
43.
WeidenP.L., ZuckermanN., HansenJ.A., SaleG.E., RemlingerK., BeckT.M., BucknerC.D.Fatal graft-versus-host disease in a patient with lymphoblastic leukemia following normal granulocyte transfusion. Blood1981; 57: 328–332.
44.
RosenR.C., HuestisD.W., CorriganJ.J.Jr.Acute leukemia and granulocyte transfusion: Fatal graft-versus-host disease following transfusion of cells obtained from normal donors. J Pediatr1978; 93: 268–271.
45.
WardH.N.Pulmonary infiltrates associated with leukoagglutinin transfusion reactions. Ann Intern Med1970; 73: 689–694.
46.
AppelbaumF.R., TrapaniR.J., GrawR.G.Jr.Consequences of prior alloimmunization during granulocyte transfusion. Transfusion1977; 17: 460–464.
47.
ThompsonJ.S., SeversonC.D., ParmelyM.J., MamorsteinB.L., SimmonsA.Pulmonary hypersensitivity reactions induced by transfusions of non-HLA agglutinins. N Engl J Med1971; 284: 1120–1125.
48.
KarpD.D., ErvinT.J., TuttleS.Pulmonary complications during granulocyte transfusions: incidence and clinical features. Vox Sang1982; 42: 57–61.
49.
WrightD.G., RobichaumK.J., PizzoP.A., DeisserothA.B.Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med1981; 304: 1185–1189.
50.
BoxerL.A., IngrahamL.M., AllenJ., OseasR.S., BaehnerR.L.Amphotericin B promotes leukocyte aggregation of nylon-wool-fiber treated polymorphonuclear leukocytes. Blood1981; 58: 518–523.
51.
WestrickM.A., Debelak-FehirK.M., EpsteonR.B.The effect of prior whole blood transfusion on subsequent granulocyte support in leukopenic dogs. Transfusion1977; 17: 611–614.
52.
ThorsbyE.HLA antigens on human granulocytes studies with cytotoxic iso-antisera obtained by skin grafting. Scand J Haematol1969; 6: 119–124.
53.
RosensheinM.S., FarewellV.T., PriceT.H., LarsonE.B., DaleD.C.The cost effectiveness of therapeutic and prophylactic leukocyte transfusions. N Engl J Med1980; 302: 1058–1062.
54.
YomtovianR.Granulocyte transfusion therapy in chronic granulomatous disease. Transfusion1980; 21: 739–743.
55.
GuinanE.C., SieffC.A., OetteD.H., NathanD.G.A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood1990; 76: 1077–1082.
56.
JakubowskiA.A., SouzaL., KellyF., FainK., BudmanD., ClarksonB., BonillaM.A., MooreM.A.S., GabriloveJ.Effects of granulocyte colony-stimulating factor in a patient with idiopathic neutropenia. N Engl J Med1989; 320: 38–42.
57.
BonillaM.A., GillioA.P., RuggeiroM., KernanN.A., BrochsteinJ.A., AbboudM., FumagalliL., VincentM., GabriloveJ.L., WelteK., SouzaL.M., O'ReillyR.J.Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med1989; 320: 1574–1580.
58.
GianniA.M., BregniM., SienaS., OraziA., SternA.C., GandolaL., BonadonnaG.Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol1990; 8: 768–778.
59.
AntmanK.S., GriffinJ.D., EliasA., SocinskiM.A., RyanL., CannistraS.A., OetteD., WhitleyM., FreiE3rd, SchnipperL.E.Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. N Engl J Med1988; 319: 593–598.
60.
LindemannA., HerrmannF., OsterW., HaffnerG., MeyenburgW., SouzaL.M., MertelsmanR.Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy. Blood1989; 74: 2644–2651.
61.
MertelsmanR., HerrmannF., HechtT., SchulzG.Hematopoietic growth factors in bone marrow transplantation. Bone Marrow Transplant1990; 6: 73–77.
